Gio1ottobre
Programma
- Thursday, october 1 – catalunya room
- I session 10.00 – 13.45 / obesity, diabetes and lipidic metabolism – part 1
- 10:00Mechanisms underlying obesityLeonardo De Luca
- 10:15Obesity and cardiovascular healthFederico Nardi
- 10:30Tirzepatide for Obesity Treatment and Diabetes PreventionGiuseppe Patti
- 10:45Semaglutide for the treatment of obesityClaudio Bilato
- 11:00Novel Targets and therapeutic agent in diabetes mellitusAngelo Avogaro
- 11:15Discussion
- I session 10.00 – 13.45 / obesity, diabetes and lipidic metabolism – part 2
- 11:30Homozygous Familial HypercholesterolemiaMaurizio Averna
- 11:45Autosomal recessive hypercholesterolemiaMarcello Arca
- 12:00Lipoprotein(a) as a Risk Factor for Cardiovascular Diseases: Pathophysiology and TreatmentAlberigo Catapano
- 12:15Inclisiran in HypercholesterolemiaPasquale Perrone Filardi
- 12:30Bempedoic Acid: for Whom and WhenAlberto Corsini
- 12:45Icosapent etile new opportunity or false hope?Alberto Zambon
- 13:00Efficacy of Lomitapide and Evinacumab in the treatment of homozygous familial hypercholesterolemia (HoFH)Marcello Arca
- 13:15PCSK9 Inhibitors “the present and the future”Piera Angelica Merlini
- 13:30Discussion
- 13:45Lunch
- II session – 14.30 – 19.00 / pulmonary hypertension
- 14:30Pulmonary arterial Hypertension: haemodinamic definition and clinical classificationDario Vizza
- 14:45Right ventricular phenotiping in idiopatic pulmonary hypertensionStefano Ghio
- 15:00Right ventricular function in PAHSilvia Papa
- 15:15Advanced in medical therapy for PAHEmanuele Romeo
- 15:30Post Capillary Pulmonary HypertensionRaymond Benza
- 15:45Pulmonary hypersension in interstizial lung diseaseDavid Montani
- 16:00Overview of the Treatment of Chronic Thromboembolic Pulmonary HypertensionAndrea D’Armini
- 16:15Sotatercept for the Treatment of Pulmonary Arterial HypertensionLaurent Savale
- 16:30Pulmonary veno-occlusive diseaseSabina Solinas
- 16:45Discussion
- III session – 17.00 – 16.45 / heart failure
- 17:00Old and New Drugs for Heart FailureMichele Senni
- 17:15Finerenone in Heart Failure with Mildly Reduced or Preserved Ejection FractionSavina Nodari
- 17:30Effects of SGLT2 Inhibitors on Kidney and Cardiovascular FunctionNadia Aspromonte
- 17:45SGLT2 inhibitor: the key of immortality?Gennaro Cice
- 18:00Diabetic Cardiomyopathy: What Clinicians Should KnowDomenico Gabrielli
- 18:15Overlap between myocarditis and dilated or arrhythmogenic cardiomyopathiesGianfranco Sinagra
- 18:30Mechanical circulatory support devices in advanced heart failureFabrizio Oliva
- 18:45Surgical Approaches in Heart FailureBastian Schmack
- 19:00Discussion
- 19:15End of the day